provided initial evidence of Tim-3's inhibitory role as a checkpoint receptor on T cells by introducing Tim-3 monoclonal antibodies in vivo, which worsened symptoms in an experimental autoimmune encephalomyelitis model (108). The gene discussed is HAVCR2; the disease is experimental autoimmune encephalomyelitis.